Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Daichi Hayashi, Frank W. Roemer & Ali Guermazi. (2021) How to effectively utilize imaging in disease-modifying treatments for osteoarthritis clinical trials: the radiologist’s perspective. Expert Review of Molecular Diagnostics 21:7, pages 673-684.
Read now
Read now
Weiyu Han, Shicai Fan, Xiaochun Bai & Changhai Ding. (2017) Strontium ranelate, a promising disease modifying osteoarthritis drug. Expert Opinion on Investigational Drugs 26:3, pages 375-380.
Read now
Read now
Kang Wang, Jianhua Xu, David J Hunter & Changhai Ding. (2015) Investigational drugs for the treatment of osteoarthritis. Expert Opinion on Investigational Drugs 24:12, pages 1539-1556.
Read now
Read now
Sara Tenti, Sara Cheleschi, Giacomo Maria Guidelli, Mauro Galeazzi & Antonella Fioravanti. (2014) What about strontium ranelate in osteoarthritis? Doubts and securities. Modern Rheumatology 24:6, pages 881-884.
Read now
Read now
Peter SE Davies, Simon M Graham, Robert J MacFarlane, Andreas Leonidou, Athanasios Mantalaris & Eleftherios Tsiridis. (2013) Disease-modifying osteoarthritis drugs: in vitro and in vivo data on the development of DMOADs under investigation. Expert Opinion on Investigational Drugs 22:4, pages 423-441.
Read now
Read now
Cyrus Cooper, Jean-Yves Reginster, Roland Chapurlat, Claus Christiansen, Harry Genant, Nicholas Bellamy, William Bensen, Federico Navarro, Janusz Badurski, Evgeny Nasonov, Xavier Chevalier & Philip N. Sambrook. (2012) Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial. Current Medical Research and Opinion 28:2, pages 231-239.
Read now
Read now
Articles from other publishers (33)
Huiqing Gang, Jingwen Zuo, Zhenxian Jia, Hongxiu Liu, Wei Xia, Shunqing Xu, Ye Shen & Yuanyuan Li. (2023) Trimester-Specific Urinary Strontium Concentrations during Pregnancy and Longitudinally Assessed Fetal Growth: Findings from a Prospective Cohort. The Journal of Nutrition.
Crossref
Crossref
K.V. Sarath, E. Shaji & V. Nandakumar. (2023) Characterization of trace and heavy metal concentration in groundwater: A case study from a tropical river basin of southern India. Chemosphere 338, pages 139498.
Crossref
Crossref
Benny Antony & Ambrish Singh. (2021) Imaging and Biochemical Markers for Osteoarthritis. Diagnostics 11:7, pages 1205.
Crossref
Crossref
Hao Peng, Feifei Yao, Shuang Xiong, Zhonghua Wu, Geng Niu & Taotao Lu. (2021) Strontium in public drinking water and associated public health risks in Chinese cities. Environmental Science and Pollution Research 28:18, pages 23048-23059.
Crossref
Crossref
Kássya Mycaela Paulino Silva, Francisco Lucas de Sousa, Ana Carolina Barreto Alves, Pollyana Alves Rocha, Hildegard Naara Alves Furtado da Costa, Waldilene Rodrigues Ferreira, Taianara Sampaio Reis, Tharcia Kiara Beserra de Oliveira, Sandra Rejane Cabral Batista, Clovis José Cavalcanti Lapa Neto, Anne Gabrielle Oliveira & Ana Janaina Jeanine M. de Lemos Jordão. (2021) Chondroprotective effect of melatonin and strontium ranelate in animal model of osteoarthritis. Heliyon 7:4, pages e06760.
Crossref
Crossref
Jean-Charles Rousseau, Roland Chapurlat & Patrick Garnero. (2021) Soluble biological markers in osteoarthritis. Therapeutic Advances in Musculoskeletal Disease 13, pages 1759720X2110403.
Crossref
Crossref
Zhenda Zhao, Qizhao Tan, Ai Jiang, Shang Sun, Zhongjun Liu, Weishi Li, Chunli Song & Huijie Leng. (2020) Evidence of subchondral bone’s effects on articular cartilage damage in OVX-OA rat. Engineering Fracture Mechanics 233, pages 107081.
Crossref
Crossref
Peilin Hu, Jie Du, Shuai Zhang, Ting Wang, Jun Li, Gang Chen & Guangqian Zhou. (2019) Oral Administration of Strontium Gluconate Effectively Reduces Articular Cartilage Degeneration Through Enhanced Anabolic Activity of Chondrocytes and Chondrogenetic Differentiation of Mesenchymal Stromal Cells. Biological Trace Element Research 193:2, pages 422-433.
Crossref
Crossref
F.W. Roemer, J. Collins, C.K. Kwoh, M.J. Hannon, T. Neogi, D.T. Felson, D.J. Hunter, J.A. Lynch & A. Guermazi. (2020) MRI-based screening for structural definition of eligibility in clinical DMOAD trials: Rapid OsteoArthritis MRI Eligibility Score (ROAMES). Osteoarthritis and Cartilage 28:1, pages 71-81.
Crossref
Crossref
Frank W. Roemer, C. Kent Kwoh, Daichi Hayashi, David T. Felson & Ali Guermazi. (2018) The role of radiography and MRI for eligibility assessment in DMOAD trials of knee OA. Nature Reviews Rheumatology 14:6, pages 372-380.
Crossref
Crossref
T.A. Rodrigues, A.O. Freire, B.F. Bonfim, M.S.S. Cartágenes & J.B.S. Garcia. (2018) Strontium ranelate as a possible disease-modifying osteoarthritis drug: a systematic review. Brazilian Journal of Medical and Biological Research 51:8.
Crossref
Crossref
G. Iolascon, F. Gimigliano, A. Moretti, A. de Sire, A. Migliore, M.L. Brandi & P. Piscitelli. (2017) Early osteoarthritis: How to define, diagnose, and manage. A systematic review. European Geriatric Medicine 8:5-6, pages 383-396.
Crossref
Crossref
A.G.H. Mierzwa, J.F. Campos, M.F. Jesus, H.B. Nader, M. Lazaretti-Castro & R.D. Reginato. (2017) Different doses of strontium ranelate and mechanical vibration modulate distinct responses in the articular cartilage of ovariectomized rats. Osteoarthritis and Cartilage 25:7, pages 1179-1188.
Crossref
Crossref
Sarah ThysenFrank P. LuytenRik J. U. Lories. (2015) Targets, models and challenges in osteoarthritis research. Disease Models & Mechanisms 8:1, pages 17-30.
Crossref
Crossref
Christian J. H. Veillette & Igor Jurisica. 2015. Osteoarthritis. Osteoarthritis
257
270
.
X.L. Yuan, H.Y. Meng, Y.C. Wang, J. Peng, Q.Y. Guo, A.Y. Wang & S.B. Lu. (2014) Bone?cartilage interface crosstalk in osteoarthritis: potential pathways and future therapeutic strategies. Osteoarthritis and Cartilage 22:8, pages 1077-1089.
Crossref
Crossref
David M. Findlay & Gerald J Atkins. (2014) Osteoblast-Chondrocyte Interactions in Osteoarthritis. Current Osteoporosis Reports 12:1, pages 127-134.
Crossref
Crossref
Kevin W.-H. Lo, Tao Jiang, Keith A. Gagnon, Clarke Nelson & Cato T. Laurencin. (2014) Small-molecule based musculoskeletal regenerative engineering. Trends in Biotechnology 32:2, pages 74-81.
Crossref
Crossref
Jorge A. Roman-Blas, Santos Casta?eda, Raquel Largo, Willem F. Lems & Gabriel Herrero-Beaumont. (2014) An OA phenotype may obtain major benefit from bone-acting agents. Seminars in Arthritis and Rheumatism 43:4, pages 421-428.
Crossref
Crossref
M.A. Karsdal, C. Christiansen, C. Ladel, K. Henriksen, V.B. Kraus & A.C. Bay-Jensen. (2014) Osteoarthritis – a case for personalized health care?. Osteoarthritis and Cartilage 22:1, pages 7-16.
Crossref
Crossref
Jean-Yves Reginster, Charlotte Beaudart, Audrey Neuprez & Olivier Bruyère. (2013) Strontium ranelate in the treatment of knee osteoarthritis: new insights and emerging clinical evidence. Therapeutic Advances in Musculoskeletal Disease 5:5, pages 268-276.
Crossref
Crossref
M.J. Kyrkos, K.A. Papavasiliou, E. Kenanidis, E. Tsiridis, F.E. Sayegh & G.A. Kapetanos. (2013) Calcitonin delays the progress of early-stage mechanically induced osteoarthritis. In vivo, prospective study. Osteoarthritis and Cartilage 21:7, pages 973-980.
Crossref
Crossref
M. K. Javaid & N. K. Arden. (2013) Editorial: Bone and Osteoarthritis: What Is the Relationship?. Arthritis & Rheumatism 65:6, pages 1418-1420.
Crossref
Crossref
Simon C. Mastbergen, Daniël B. F. Saris & Floris P. J. G. Lafeber. (2013) Functional articular cartilage repair: here, near, or is the best approach not yet clear?. Nature Reviews Rheumatology 9:5, pages 277-290.
Crossref
Crossref
Irene E. M. Bultink & Willem F. Lems. (2013) Osteoarthritis and Osteoporosis: What Is the Overlap?. Current Rheumatology Reports 15:5.
Crossref
Crossref
Jean-Yves Reginster, Franz Pelousse & Olivier Bruyère. (2013) Is there potential for strontium ranelate in the management of osteoarthritis?. Clinical Practice 10:2, pages 201-207.
Crossref
Crossref
De-gang Yu, Hui-feng Ding, Yuan-qing Mao, Ming Liu, Bo Yu, Xin Zhao, Xiao-qing Wang, Yang Li, Guang-wang Liu, Shao-bo Nie, Shen Liu & Zhen-an Zhu. (2013) Strontium ranelate reduces cartilage degeneration and subchondral bone remodeling in rat osteoarthritis model. Acta Pharmacologica Sinica 34:3, pages 393-402.
Crossref
Crossref
René Rizzoli. 2013. Osteoporosis. Osteoporosis
1935
1947
.
P. Richette & C. Roux. (2012) Impact of treatments for osteoporosis on cartilage biomarkers in humans. Osteoporosis International 23:S8, pages 877-880.
Crossref
Crossref
Johanne Martel-Pelletier, Lukas M. Wildi & Jean-Pierre Pelletier. (2012) Future therapeutics for osteoarthritis. Bone 51:2, pages 297-311.
Crossref
Crossref
W.E. van Spil, N.W.D. Jansen, J.W.J. Bijlsma, M. Reijman, J. DeGroot, P.M.J. Welsing & F.P.J.G. Lafeber. (2012) Clusters within a wide spectrum of biochemical markers for osteoarthritis: data from CHECK, a large cohort of individuals with very early symptomatic osteoarthritis. Osteoarthritis and Cartilage 20:7, pages 745-754.
Crossref
Crossref
J.-J. Body, P. Bergmann, S. Boonen, J.-P. Devogelaer, E. Gielen, S. Goemaere, J.-M. Kaufman, S. Rozenberg & J.-Y. Reginster. (2012) Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications. Osteoporosis International 23:S1, pages 1-23.
Crossref
Crossref
Steeve Kwan Tat, Jean-Pierre Pelletier, François Mineau, Judith Caron & Johanne Martel-Pelletier. (2011) Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts. Bone 49:3, pages 559-567.
Crossref
Crossref